Despite certain limitations, such as obesity, ascites, cholestasis effects, and elevated ALT levels, technological advancements—including XL probes, Guided-VCTE, and 2D-SWE—have significantly improved measurement accuracy and expanded its clinical applicability [60,61,62,63,64,71]. Here, GPT is linked to obesity due to melanocortin 4 receptor deficiency.